Group 3 Innate Lymphoid Cells Inhibit T-Cell-Mediated Intestinal Inflammation through Aryl Hydrocarbon Receptor Signaling and Regulation of Microflora  by Qiu, Ju et al.
Immunity
ArticleGroup 3 Innate Lymphoid Cells Inhibit T-Cell-Mediated
Intestinal Inflammation through Aryl Hydrocarbon
Receptor Signaling and Regulation of Microflora
Ju Qiu,1,2 Xiaohuan Guo,3 Zong-ming E. Chen,1 Lei He,1,2 Gregory F. Sonnenberg,4 David Artis,5,6 Yang-Xin Fu,3
and Liang Zhou1,2,*
1Department of Pathology
2Department of Microbiology-Immunology
Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
3Department of Pathology, Committee on Immunology, University of Chicago, Chicago, IL 60637, USA
4Department of Medicine, Division of Gastroenterology
5Department of Microbiology
6Institute for Immunology
Perelman School of Medicine, University of Pennsylvania, 421 Curie Boulevard, Philadelphia, PA 19104-6160, USA
*Correspondence: l-zhou@northwestern.edu
http://dx.doi.org/10.1016/j.immuni.2013.08.002SUMMARY
Aryl hydrocarbon receptor (Ahr) is crucial for the
maintenance and function of group 3 innate
lymphoid cells (ILCs), which are important in gut
immunity. Because Ahr promotes T helper 17 (Th17)
cell differentiation in vitro, it is reasonable to expect
that Ahr would enhance Th17 cells in vivo. Instead,
we show that Ahr deficiency caused increased intes-
tinal Th17 cells, raising the possibility that group 3
ILCs could negatively regulate Th17 cells. Reduced
innate interleukin-22 (IL-22) in Ahr-deficient mice
allowed expansion of commensal segmented
filamentous bacteria (SFB), known to promote
Th17 cells. Compared to Rorc+/+Ahr/ mice,
Rorcgfp/+Ahr/ mice had further reduced group
3 ILCs and were prone to spontaneous colitis with
increased SFB and Th17 cells. Innate expression
of Ahr played a protective role in T-cell-mediated
experimental colitis by suppressing pathogenic
Th17 cells. Our data reveal an intricate balance
between ILCs and Th17 cells regulated by Ahr and
commensal flora.
INTRODUCTION
T helper 17 (Th17) cells, characterized by the expression of the
orphan nuclear receptor RORgt, secrete the signature cytokines
interleukin-17A (IL-17A) (hereafter referred to as IL-17), IL-17F,
and IL-22 (Ivanov et al., 2006). Th17 cells are most abundant
under steady-state conditions in mucosal tissues and are
required for clearing certain bacterial or fungal infections at
mucosal surfaces (Aujla et al., 2008; Mangan et al., 2006; Zheng
et al., 2008). Th17 cell differentiation is influenced by the local
cytokine milieu (Bettelli et al., 2008; Korn et al., 2007; Mangan
et al., 2006; Nurieva et al., 2007; Veldhoen et al., 2006; Zhou386 Immunity 39, 386–399, August 22, 2013 ª2013 Elsevier Inc.et al., 2007) and specific microflora (Gaboriau-Routhiau et al.,
2009; Ivanov et al., 2009). Coordinated actions of various tran-
scription factors are crucial for Th17 cell differentiation (Zhou
and Littman, 2009). Dysregulated Th17 cell responses result in
autoimmune diseases in mice and in humans (Korn et al.,
2009). Recent data have shown that Th17 cells that coexpress
IL-17 and interferon-g (IFN-g) are especially pathogenic in
certain disease settings (Ahern et al., 2010; Kebir et al., 2009).
For example, pathogenic Th17 cells (IL-17+IFN-g+ cells) are
prominent in animal models of colitis (Hue et al., 2006; Kullberg
et al., 2006) and have also been recovered from the intestinal
lesions of patients with human inflammatory bowel disease
(IBD) (Annunziato et al., 2007; Cosmi et al., 2008).
Innate lymphoid cells (ILCs) represent an emerging family of
cell types, consisting of T-bet+ group 1 ILCs (including natural
killer [NK] cells and other ILC1 cells [ILC1s]), Gata3+ group 2
ILCs (ILC2s), and RORgt+ group 3 ILCs (Spits et al., 2013;Walker
et al., 2013). ILCs lack T or B cell receptors, and the development
of ILCs is independent of Rag genes. Group 3 ILCs include
lymphoid tissue inducer (LTi) cells, natural cytotoxicity triggering
receptor (NCR)+ ILC3s, and colitogenic NCR ILC3s. Although
NCR+ ILC3s express NK markers (NKp46 in mice and NKp44
in humans) (Cella et al., 2009; Cupedo et al., 2009; Luci et al.,
2009; Sanos et al., 2009; Takayama et al., 2010), recent fate-
mapping experiments have suggested that NCR+ ILC3s that pro-
duce IL-22 are not derived from conventional NK cells (Sawa
et al., 2010; Vonarbourg et al., 2010). Instead, they share a com-
mon progenitor with LTi cells and require transcription factor Id2
for their development (Yokota et al., 1999).
Group 3 ILCs strikingly resemble Th17 cells in their cytokine
profile (e.g., production of IL-22 and/or IL-17) (Sonnenberg
et al., 2011; Tumanov et al., 2011; Wang et al., 2010), and thus
coevolution of two systems might be a fail-safe mechanism for
implementing redundancy into host immunity to certain infec-
tions, especially at mucosal surfaces. Consistent with this
notion, although Rag-deficient mice lack Th17 cells, group 3
ILCs are increased in the absence of the adaptive immune sys-
tem (Qiu et al., 2012; Sawa et al., 2011). It has been shown
that intestinal Th17 cell responses are enhanced by Citrobacter
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Inhibition of Intestinal Th17 Responses by ILCsrodentium, a murine pathogen that models human enterohemor-
rhagic E. coli and enteropathogenic E. coli infections (Mangan
et al., 2006). Most recently, it has been reported that ILC-
produced IL-22 is essential for clearance of C. rodentium in the
intestines (Sonnenberg et al., 2011; Zheng et al., 2008). Intrigu-
ingly, even in the lymphocyte-replete hosts, mice lacking
RORgt+ ILCs died from C. rodentium infection (Sonnenberg
et al., 2011). An intact ILC compartment is also important for pre-
venting peripheral dissemination of commensal bacteria (i.e.,
Alcaligenes species) that normally reside in host lymphoid tis-
sues (Sonnenberg et al., 2012). These data highlight an essential
role for ILCs in host immunity against overt pathogens and
opportunistic commensals.
Segmented filamentous bacteria (SFB), a type of intestinal
commensal found in mice, have been shown to be important
for in vivo Th17 induction (Gaboriau-Routhiau et al., 2009; Ivanov
et al., 2009). Mice lacking SFB show a substantial reduction in
Th17 cells in the small intestine, and monocolonization of gnoto-
biotic mice with SFB can restore intestinal Th17 cells (Ivanov
et al., 2009). Although microbiota can promote or suppress IL-
22 production by group 3 ILCs (Sanos et al., 2009; Satoh-
Takayama et al., 2008; Sawa et al., 2011), the development of
group 3 ILCs seems to be independent of gut flora or SFB (Rey-
nders et al., 2011; Sawa et al., 2010). The impact of group 3 ILCs
on gut flora, especially commensal bacteria, however, remains
to be elucidated.
Recent data suggest a similarity between ILCs and T helper
cells in transcriptional regulation (Zhou, 2012). T-bet, a Th1-
cell-lineage transcription factor, has been shown to be important
for IFN-g production by certain ILCs (Bernink et al., 2013; Buono-
core et al., 2010; Klose et al., 2013; Powell et al., 2012; Sciume´
et al., 2012). Gata3, a key transcription factor for Th2 cells, is
crucial for ILC2 development and function (Hoyler et al., 2012;
Mjo¨sberg et al., 2012). RORgt, a common transcription factor
shared by Th17 cells and group 3 ILCs, is not only important
for Th17 cell differentiation but is also essential for group 3 ILC
development (Eberl et al., 2004; Ivanov et al., 2006). Aryl hydro-
carbon receptor (Ahr) is a ligand-dependent transcription factor
best known for mediating the carcinogenicity of a family of envi-
ronmental contaminants (i.e., xenobiotic ligands). Recent data
suggest that Ahr also plays an important physiological role in
the immune system (Stockinger et al., 2011). The expression of
Ahr is important for the maintenance, survival, and function of
group 3 ILCs (Kiss et al., 2011; Lee et al., 2012; Qiu et al.,
2012). Ahr cooperates with RORgt to induce the transcription
of IL-22, which is essential for the clearance of C. rodentium
infection (Qiu et al., 2012). Although Ahr is expressed by both
intestinal Th17 cells and group 3 ILCs and promotes in vitro
Th17 cell differentiation (i.e., enhances IL-17 expression in
CD4+ T cells) (Kimura et al., 2008; Quintana et al., 2008; Veld-
hoen et al., 2008), it remains to be determined whether Ahr plays
a role in the regulation of in vivo Th17 cell responses especially in
the gut, a location where Th17 cells and group 3 ILCs are both
prominently present in the steady-state physiological conditions.
The crosstalk between ILCs and the adaptive immune system
(e.g., T cells) has recently been investigated. Despite rapid early
ILC2 expansion after infection, analysis of ILC2 numbers in
N. brasiliensis-infected Rag2/ mice showed that ILC2
numbers were not maintained, suggesting that T cells mediateprolonged ILC2 expansion, migration, and/or survival through
an as yet unknown mechanism (Neill et al., 2010). Compared
to those in the immune-competent mice, group 3 ILCs in Rag-
deficient mice that lacked both T and B cells produced higher
amounts of IL-22, suggesting that the adaptive immunity might
suppress the function of RORgt+ ILCs (Sawa et al., 2011). In
this study, we have shown a regulatory role for ILCs in controlling
Th17 cell responses and the importance of an Ahr-IL-22 axis in
the maintenance of gut immune homeostasis via regulation of
gut commensal flora.
RESULTS
Enhanced Th17 Responses in the Small Intestine ofAhr-
Deficient Mice
Ahr has been shown to promote IL-17 expression in vitro (Kimura
et al., 2008; Quintana et al., 2008; Veldhoen et al., 2008). To
determine the impact of Ahr on Th17 cell responses in vivo, we
measured the cytokine expression in the intestinal lamina prop-
rial lymphocytes (LPLs) isolated from Ahr/mice and their litter-
mate control mice. Unexpectedly, we observed an upregulation
of IL-17 expression by small-intestinal CD4+ T cells (i.e., IL-
17+IFN-g and IL-17+IL-22 cells) in Ahr–/– mice (Figures 1A–
1C and Figure S1, available online). IFN-g+IL-17CD4+ T cells
were also substantially increased in Ahr/ mice (Figures 1A
and 1B). IL-22-expressing CD4+ T cells (i.e., IL-22+IL-17 cells)
were reduced in the absence of Ahr (Figures 1A and 1C), consis-
tent with an important role of Ahr in promoting IL-22 production
in T cells (Basu et al., 2012; Quintana et al., 2008; Veldhoen et al.,
2008). These data suggest that Ahr is required for suppressing
in vivo Th17 cell differentiation (i.e., IL-17-producing CD4+
T cells) in the gut under the steady state; this role contrasts
with its function in promoting IL-17 expression by T cells
in vitro. Although the increase in Th17 cells is most readily
evident in the small intestine, it is known that intestinal Th17
cell responses can have an impact on systemic immune
compartment (Wu et al., 2010). Indeed, we consistently
observed increased Th17 cells in the blood of aged Ahr/
mice (Figure 1D). Together, these data suggest that the Ahr
signaling pathway suppresses Th17 cell differentiation in vivo.
Increase in Intestinal Th17 Cells in Ahr–/– Mice Is
Dependent on RORgt
The enhancement of in vivo Th17 cells in Ahr/ mice prompted
us to investigate the potential mechanism that can bypass the
requirement for Ahr in the regulation of Th17 cell differentiation.
To this end, we examined the expression of RORgt, one of the
key transcription factors that regulate IL-17 production in
T cells in vitro and in vivo (Ivanov et al., 2006). Consistent with
the enhanced Th17 cell responses, an increased percentage of
RORgt+ cells in total CD4+ T cells was observed in the small,
but not the large, intestine of Ahr/ mice (Figures 2A and 2B).
These data argue that upregulation of RORgt expression might
compensate for the loss of Ahr and thus contribute to increased
intestinal Th17 cells in Ahr/ mice. To test this hypothesis, we
generated Ahr/Rorcgfp/gfp mice to genetically ablate RORgt
expression in Ahr/ T cells. Indeed, the production of IL-17
and IL-22 by CD4+ T cells was greatly reduced in the small-intes-
tinal LPLs of Ahr/Rorcgfp/gfp mice compared to Ahr/ miceImmunity 39, 386–399, August 22, 2013 ª2013 Elsevier Inc. 387
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Figure 1. Th17 Cells Were Enhanced in the Small Intestine of Ahr-Deficient Mice
(A–C) Small-intestinal (‘‘SI’’) and large-intestinal (‘‘LI’’) LPLs were isolated from Ahr/ and littermate Ahr+/+mice. Cells were stimulated with PMA and ionomycin
for 4 hr. Expression of IFN-g, IL-17, and IL-22 in CD4+TCRb+ cells was analyzed by flow cytometry, as shown in (A). Percentages of the indicated cell populations
gated on CD4+TCRb+ cells are shown in (B) and (C).
(D) Peripheral-blood mononuclear cells from Ahr/ mice and AhrCtrl (Ahr+/+ or Ahr+/) littermate mice of the indicated ages were stimulated with PMA and
ionomycin for 4 hr. Percentages of IL-17+ cells gated on CD4+TCRb+ cells were analyzed by intracellular staining followed by flow cytometry.
Data are representative of two independent experiments. Horizontal lines show the mean. Error bars represent the SEM. Statistical analyses were performed
using Mann-Whitney paired U test. See also Figure S1.
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expressionmight account for the elevated production of IL-17 by
CD4+ T cells in the intestinal LPLs of Ahr/ mice.
Microbiota-Dependent Increase of Th17 Cells and
Aberrant Expansion of SFB without Ahr
Specific microbiota (e.g., SFB) play an important role in the
induction of RORgt expression in CD4+ T cells, thus promoting
the in vivo Th17 cell differentiation, particularly in the small intes-
tine (Gaboriau-Routhiau et al., 2009; Ivanov et al., 2009). To388 Immunity 39, 386–399, August 22, 2013 ª2013 Elsevier Inc.determine whether the increase in Th17 cells in the absence of
Ahr was also dependent on gut flora, we treated Ahr/ mice
with a cocktail of broad-spectrum antibiotics. IL-17 production
by CD4+ T cells in both the small-intestinal lamina propria and
spleens of Ahr/ mice was greatly decreased after antibiotic
treatment (Figure 3A), suggesting a contribution of microbiota
to the increase in Th17 cells in Ahr/ mice. These data promp-
ted us to further examine the composition of commensal micro-
flora in Ahr/ mice, especially SFB, which has been reported to
be one of the key indigenous bacterial species that promote
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Figure 2. Increased Th17 Cells in the Small
Intestine of Ahr-Deficient Mice Was Depen-
dent on RORgt
(A and B) Small-intestinal (‘‘SI’’) and large-intestinal
(‘‘LI’’) LPLswere isolated fromAhr/and littermate
Ahr+/+mice.RORgt expression inCD4+TCRb+ cells
was analyzed by flow cytometry, as shown in (A).
Percentages of RORgt+ cells gated on CD4+TCRb+
cells are shown in (B). Data are representative of
two independent experiments. Horizontal lines
show the mean. Error bars represent the SEM.
(C) Small-intestinal LPLs were isolated from
Ahr/ (n = 3) or Rorcgfp/gfpAhr/ (n = 6) littermate
mice. Cells were stimulated with PMA and ion-
omycin for 4 hr. Expression of IL-17 and IL-22 in
CD4+TCRb+ cells was analyzed by flow cytometry.
Percentages of IL-17 and IL-22 gated on CD4+
TCRb+ cells are shown. Data are representative of
three independent experiments. Horizontal lines
show the mean. Error bars represent the SEM.
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numbers in the feces reflect well those in the distal small intestine
(Kriegel et al., 2011). To monitor SFB numbers during different
treatments without sacrificing themice, wemeasured SFB levels
in the fecal pellets. Bacterial DNA was extracted from the feces
of Ahr/ mice and their cohoused littermate control mice, and
the relative amount of different bacterial species in total bacteria
was determined by real-time PCR using primers specific to 16S
rRNA genes. Strikingly, we observed a substantial increase in
SFB in the feces of Ahr/ mice compared to their littermate
controls, consistent with the role of SFB in Th17 cell induction
in the gut (Ivanov et al., 2009). No obvious differences were found
in other commensal microflora between Ahr/ mice and litter-
mate controls (Figure 3B). These data suggest that the aberrant
expansion of SFB in Ahr/ mice might contribute to the
increased Th17 cell responses in the gut.
Intact IL-22 Expression Is Important for SFB Control and
Th17 Cell Responses
We and others have reported that one of the major immune
defects of Ahr/ mice is the impaired development of group 3
ILCs and reduced IL-22 production by group 3 ILCs in the gut
(Kiss et al., 2011; Lee et al., 2012; Qiu et al., 2012). We hypothe-
sized that the aberrant expansion of SFB and subsequent upre-
gulation of Th17 cells in the gut of Ahr/ mice is most likely due
to the impaired production of IL-22, a cytokine responsible for
controlling certain bacterial infections (e.g., C. rodentium). To
determine whether overexpression of IL-22 can restrain the
expansion of SFB, we intraperitoneally injected Ahr/ mice
with IL-22-Ig (IL-22 fused to an immunoglobulin) and measured
the amount of SFB in feces 4 days after treatment. SFB inImmunity 39, 386–39Ahr/ mice were markedly downregu-
lated after IL-22-Ig treatment (Figure 3C).
Consistently, aberrant enhancement of
Th17 cells in the small intestine of Ahr/
mice was also prevented upon IL-22-Ig
treatment (Figure 3D). To further deter-
mine the role of IL-22 in curbing SFB
and Th17 cell responses, we injected IL-22-specific neutralizing antibody or control IgG into wild-type
mice. Ten days after treatment, we measured the level of SFB
in the fecal pellets and/or in the luminal contents of the small
intestine. Substantial expansion of SFB, but not other bacterial
species, was detected in IL-22-depleted mice, suggesting a
role for IL-22 in controlling the expansion of SFB, but not other
bacterial species, in the gut (Figures 3E and 3F and Figure S2A).
Consistent with the expansion of SFB, an increase in Th17 cells
in the small intestine was observed in IL-22-depleted mice (Fig-
ure 3G). Together, these data demonstrate that Ahr functions as
a regulator to control SFB growth and small-intestinal Th17 re-
sponses in an IL-22-dependent manner.
Ahr is expressed by both innate lymphoid cells (i.e., group 3
ILCs) and T cells (e.g., gd T, Th17, and Th22 cells) to control
gut microflora (Basu et al., 2012; Martin et al., 2009; Sonnenberg
et al., 2011; Upadhyay et al., 2012; Zheng et al., 2008). We bred
Ahrf/f mice with Rorc-cre mice to delete Ahr specifically in
RORgt+ cells. Similar to Ahr/ mice, Ahrf/fRorc-cre mice have
reduced group 3 ILCs (Kiss et al., 2011; Lee et al., 2012; data
not shown). Fecal 16S rRNA gene analysis showed SFB
enhancement in Ahrf/fRorc-cre mice (Figure S2B), suggesting
that the expression of Ahr in RORgt+ cells, including group
3 ILCs, is important for the control of SFB outgrowth. To further
determine whether the enhancement of SFB in Ahr/ mice
is dependent on the adaptive immune system, we crossed
Ahr/ mice with Rag1/ mice to obtain Ahr/Rag1/ mice.
Compared to cohoused littermate controls, Ahr/Rag1/
mice had substantially higher SFB (Figure S2C), suggesting
that the outgrowth of SFB in the absence of Ahr was innate cell
intrinsic and presumably due to the loss of group 3 ILCs in
Ahr-deficient mice.9, August 22, 2013 ª2013 Elsevier Inc. 389
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Figure 3. Inhibitory Effect of IL-22 on SFB and Th17 Cells
(A) Ahr/mice were treated with or without an antibiotic cocktail in drinking water for 10 days. Small-intestinal LPLs (‘‘SI’’) and splenocytes (‘‘SP’’) were isolated
and stimulated with PMA and ionomycin for 4 hr. Expression of IL-17, IFN-g, and IL-22 gated on CD4+TCRb+ cells were analyzed by flow cytometry. Data are
representative of two independent experiments.
(B) Bacterial DNA from fecal pellets was extracted from cohoused Ahr/ (n = 4) or Ahr+/+ (n = 4) littermate mice. The amount of the indicated bacteria species
relative to universal bacteria was analyzed by real-time PCR with primers specific to 16S rRNA genes. Error bars represent the SEM. Data are representative of
two independent experiments.
(C) At day 0, AhrCtrl (Ahr+/+ orAhr+/) mice (n = 3) were treated with PBS. Ahr/mice were treated with PBS (n = 4) or IL-22-Ig (n = 4). Bacterial DNAwas extracted
from fecal pellets, and the amount of SFB relative to universal bacteria was analyzed at the indicated time points by real-time PCR using primers specific to 16S
rRNA genes. Statistical analyses were performed with the Mann-Whitney U test. Horizontal lines show the mean. Error bars represent the SEM.
(D) Small-intestinal LPLs were isolated on day 10 after IL-22-Ig injection and stimulated with PMA and ionomycin. Expression of IL-17 and IL-22 gated on
CD4+TCRb+ cells was analyzed by flow cytometry.
(E–G) Wild-type mice were intraperitoneally injected with control IgG (n = 8) or IL-22-specific neutralizing antibody (n = 7) every 4 days. Bacterial DNA was
extracted from fecal pellets (E) or contents of the small intestine (F) of the mice 10 days after treatment. The amount of SFB relative to universal bacteria was
analyzed by real-time PCR using primers specific to 16S rRNA genes. Horizontal lines show the mean. Error bars represent the SEM. Small and large intestinal
LPLs were isolated and stimulated with PMA and ionomycin (G). Expression of IL-17 and IL-22 gated on CD4+TCRb+ cells was analyzed by flow cytometry. Data
are representative of two independent experiments.
See also Figure S2.
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Figure 4. ILCs Inhibit SFB and Th17 Cells in the Gut
(A) Rag1/ mice were injected with control IgG (n = 4) or anti-Thy1.2 antibody (n = 3) every 3 days. Fecal DNA was extracted at day 7, and the amount of
SFB relative to universal bacteria was analyzed by real-time PCR using primers specific to 16S rRNA genes. Horizontal lines show the mean. Error bars represent
the SEM.
(B and C) A total of 43 105 CD4+CD25CD45RBhiThy1.1+ splenocytes were sorted by flow cytometry and transferred to Rag1/ mice. Mice were injected with
control IgG or Thy1.2-specific neutralizing antibody on the same day of the transfer and then every 3 days after the transfer. Mice were sacrificed at day 10 after
the adoptive T cell transfer. Small-intestinal LPLs were isolated and stimulated with PMA and ionomycin for 4 hr. Expression of IL-17 and IFN-g gated on
CD4+TCRb+ cells was analyzed by flow cytometry, as shown in (B). Percentages of IL-17+, IFN-g+, and IL-22+ cells gated on CD4+TCRb+ cells are shown in (C).
Horizontal lines show the mean. Error bars represent the SEM. Data are representative of two independent experiments.
See also Figure S3.
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Inhibition of Intestinal Th17 Responses by ILCsDepletion of ILCs Leads to Upregulation of SFB and
Enhanced Th17 Cell Responses
To elucidate the role of ILCs in restraining SFB outgrowth, we
attempted to ablate ILCs by using Thy1 antibody in Rag1/
mice. Consistent with previous reports (Buonocore et al., 2010;
Sonnenberg et al., 2011), Thy1.2 antibody effectively reduced
IL-22-producing ILCs in the intestines of Rag1/ mice (Fig-
ure S3A). Reduction of ILCs in Rag1/ mice led to marked
enhancement of SFB, suggesting a key role for ILCs in suppress-
ing commensal SFB under the steady state (Figure 4A). To deter-
mine the impact of ILC depletion on intestinal Th17 cell
responses, we developed a Rag1/ chimeric mouse model
with the reconstitution of wild-type T cells. Specifically, we in-
jected Thy1.2 antibody or control IgG into Rag1/ Thy1.2 hosts
while adoptively transferring CD45RBhiCD4+ T cells purified from
wild-type Thy1.1 congenic donors. On day 10 after adoptive
T cell transfer and before mice developed overt wasting disease
and colitis, we examined cytokine expression by intestinal CD4+
T cells.We observed a selective upregulation of IL-17 expression
in T cells isolated from Rag1/ mice that were injected with
Thy1.2 antibody (Figures 4B and 4C), concurrent with the
enhancement of SFB (data not shown). After administration of
Thy1.2 antibody, which selectively depleted Thy1.2+ ILCs, but
not Thy1.1+ T cells, in Rag1/ chimeric mice (Figure S3B), we
observed increased lethality and accelerated and enhancedweight loss in mice depleted of Thy1+ ILCs (Figures S3C–S3F),
indicating the protective role of ILCs in T-cell-mediated inflam-
mation. Together, these data further confirm the suppressive
role of ILCs in controlling SFB and Th17 cell responses in the gut.
Spontaneous Intestinal Pathology in the Absence of Ahr
Our previous effort to study the impact of Ahr on RORgt+ ILCs
allowed us to develop Rorcgfp/+Ahr/ mice to track RORgt-
expressing cells (Qiu et al., 2012). As expected, group 3 ILCs
were decreased and had impaired expression of IL-22 in
Ahr/ mice (Qiu et al., 2012) (Figure 5A). Intriguingly, compared
to littermate Rorc+/+Ahr/ mice, Rorcgfp/+Ahr/ mice had
further decreased group 3 ILCs and reduced expression of
RORgt on a per-cell basis in the gut (Figure 5A). The remaining
group 3 ILCs in Rorcgfp/+Ahr/ mice produced even less IL-22
than did those in Rorc+/+Ahr/ mice (Figure 5B). These data
suggest that genetic ablation of Ahr with haplodeficiency of
RORgt leads to further loss of group 3 ILC compartment and
function.
It is worthmentioning thatRorc+/+Ahr/mice bred under spe-
cific-pathogen-free (SPF) conditions in our animal facility
showed no overt signs of colitis up to 1 year of age (data not
shown). Although no colitis developed in young (6- to 8-week-
old) Rorcgfp/+Ahr/ mice, we observed that about 40% of
aged (12- to 20-week-old) Rorcgfp/+Ahr/ mice spontaneouslyImmunity 39, 386–399, August 22, 2013 ª2013 Elsevier Inc. 391
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Figure 5. Rorc gfp/+Ahr–/– Mice Developed Spontaneous Colitis
(A) Expression of RORgt in CD3 cells was analyzed by flow cytometry. Numbers in red squares show the mean fluorescence intensity of RORgt. Data are
representative of two independent experiments. ‘‘SSC’’ stands for side scatter.
(B) Cells were incubated with brefeldin A for 2 hr. The expression of IL-22 gated on CD3 cells was analyzed by flow cytometry. Data are representative of two
independent experiments.
(C) Paraffin-embedded colon sections were stained with hematoxylin and eosin (H&E). Magnification is 203.
(D) Large-intestinal LPLs were isolated and stimulated with PMA and ionomycin for 4 hr. Expression of IL-17 and IFN-g gated on CD4+TCRb+ cells was analyzed
by flow cytometry.
(E) Expression of CD11b and Gr-1 gated on live cells was analyzed by flow cytometry.
(F) Percentages of CD11b+Gr-1+ neutrophils in live cells from themice of the indicated genotypes are shown. Horizontal lines show themean. Error bars represent
the SEM. Data are representative of three independent experiments.
28-day-old mice of the indicated genotypes (A and B) or 16-week-old Rorcgfp/+Ahr/ and littermate Rorcgfp/+Ahr+/+mice (C–F) were sacrificed. Large-intestinal
LPLs were isolated from mice of the indicated genotypes in (D)–(F). See also Figure S4.
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Inhibition of Intestinal Th17 Responses by ILCsdeveloped active chronic colitis, suggesting a breach of immune
homeostasis in the absence of Ahr on an RORgt heterozygous
genetic background (Table 1). The diseased mice did not show
obvious signs of diarrhea or emaciation, but gross analysis sug-
gests a pathology involving the entire large intestine, as indi-
cated by thickening and fibrosis of the intestinal tissues (data392 Immunity 39, 386–399, August 22, 2013 ª2013 Elsevier Inc.not shown and Figure S4A). Histological analyses of the colonic
tissue further revealed acute cryptitis and crypt abscess forma-
tion, loss of goblet cells, increased lamina propria lymphoplas-
macytic infiltration with lymphoid aggregates, crypt destruction
and glandular architecture distortion, and extension of inflamma-
tion into submucosa (Figure 5C and Figure S4B), all of which
Table 1. Incidence of Spontaneous Colitis inRorcgfp/+Ahr –/–Mice
Rorcgfp/+AhrCtrl Rorcgfp/+Ahr/
Total No.
of Mice
No. of
Colitic Mice
Total No.
of Mice
No. of
Colitic Mice
Litter 1 2 0 2 1
Litter 2 2 0 2 2
Litter 3 1 0 1 0
Litter 4 2 0 2 0
Litter 5 3 0 3 0
Litter 6 2 0 3 3
Litter 7 3 0 4 0
Litter 8 2 0 2 2
16-week-old Rorcgfp/+Ahr–/– and littermate Rorcgfp/+AhrCtrl
(Rorcgfp/+Ahr+/– or Rorcgfp/+Ahr+/+) mice were monitored for colitis devel-
opment. Eight independent litters of mice are shown. Colitis was deter-
mined by macroscopic appearance of the colon (i.e., thickening and
fibrosis of the intestinal tissues) and histology.
Immunity
Inhibition of Intestinal Th17 Responses by ILCsresemble characteristic pathohistological phenotypes of human
IBD. We next measured the cytokine production by the large-
intestinal LPLs ofRorcgfp/+Ahr/ coliticmice. Therewasmarked
upregulation of IFN-g-producing CD4+ T cells, especially a
population of cells coexpressing IL-17 and IFN-g in
Rorcgfp/+Ahr/mice (Figure 5D and Figure S4C), in line with pre-
vious reports indicating that IL-17+IFN-g+CD4+ T cells are highly
pathogenic in colitis (Ahern et al., 2010; Hue et al., 2006; Kebir
et al., 2009; Kullberg et al., 2006). Consistent with upregulation
of pathogenic Th17 responses in the gut of Rorcgfp/+Ahr/
colitic mice, we also observed substantially enhanced SFB in
Rorcgfp/+Ahr/ mice compared to Rorcgfp/+Ahr+/+ or
Rorcgfp/+Ahr+/ littermate mice. Furthermore, Rorcgfp/+Ahr/
mice had higher amounts of fecal SFB than did Rorc+/+Ahr/
mice (Figures S4D and S4E). Flow cytometry analyses indicated
a prominent increase in neutrophil (GR1+CD11b+) infiltration in
the intestinal lamina propria of Rorcgfp/+Ahr/ mice, confirming
active intestinal inflammation (Figures 5E and 5F). Collectively,
these data suggest that aged Rorcgfp/+Ahr/ mice are popu-
lated with pathogenic Th17 cells that are IL-17 and IFN-g double
producers, and this might intensify gut inflammation and cause
tissue damage.
ExacerbatedGut PathologyCaused by InnateDeficiency
of Ahr
The above findings led us to hypothesize that innate expression
of Ahr might play a suppressive role in intestinal inflammation by
inhibiting proinflammatory Th17 cell responses. Because of
the incomplete penetrance of spontaneous colitis in aged
Rorcgfp/+Ahr/ mice, we decided to exploit the model of
experimental colitis to test our hypothesis. CD45RBhiCD4+ T-
cell-transfer-induced colitis mimics human IBD and is a well-
characterized model of colitis caused by disruption of T cell
homeostasis with excessive Th17 and Th1 cell responses (Ahern
et al., 2010; Powrie et al., 1994). To determine whether the innate
expression of Ahr can influence T-cell-transfer colitis, we adop-
tively transferred wild-type CD45RBhiCD4+ T cells into Rag1/
mice or Rag1/Ahr/ mice. After adoptive transfer of T cells,
Rag1/Ahr/ recipient mice had more weight loss than didRag1/ mice (Figures 6A and 6B). Rag1/Ahr/ mice devel-
oped exacerbated colitis, as revealed by loose stool, rectal
bleeding, colon edema (Figure S5A and data not shown) and
worsened histology of colon tissues (Figures 6C and 6D).
To determine the contribution of intestinal flora to gut pathol-
ogy, we treated Rag/Ahr/ mice that were transferred with
naive T cells with antibiotics to reduce gut resident bacteria,
such as SFB (Figure S5B and data not shown). Antibiotic-treated
mice showed a better gross appearance of the large intestine
with intact fecal pellets (Figure S5C). Histology analysis further
indicated that compared to untreated mice, which showed
severe goblet cell depletion, crypt abscess formation, and
superficial mucosal erosion in the colon, antibiotic-treated
mice displayed a milder increase in LPL infiltration without glan-
dular epithelial damage in the colon (Figures 6E and 6F). Consis-
tent with less inflammatory cell infiltration revealed by histology,
the number of CD4+ T cells, including IFN-g+ and IL-17+ T cells,
wasmarkedly reduced in antibiotic-treated animals (Figure S5D).
Together, these data indicate that the exacerbated colitis
observed in Rag/Ahr/ is dependent on gut flora.
Innate Expression of Ahr Suppresses Effector Cytokine
Production by T Cells
Further examination of cytokine production by adoptively trans-
ferred T cells revealed that the percentage of IFN-g-coexp-
ressing Th17 cells (i.e., IL-17-producing cells) observed in
Rag1/Ahr/ mice was substantially higher than that in
Rag1/ mice upon T cell transfer (Figures 7A and 7B), in agree-
ment with the pathogenicity of IFN-g-producing Th17 cells in
colitis. Granulocyte-macrophage colony-stimulating factor
(GM-CSF) has been shown to be pathogenic in autoimmune
diseases, including colitis (Griseri et al., 2012). Compared to
those in Rag/ mice, T cells in Rag/Ahr/ mice after adop-
tive transfer also showed enhanced GM-CSF production (Fig-
ures 7C and 7D), consistent with its contribution to exacerbated
colitis observed in Rag/Ahr/ mice. Together, these data
suggest that innate expression of Ahr plays a protective role in
CD45RBhi T-cell-induced colitis by inhibiting proinflammatory
cytokine production by T cells.
DISCUSSION
Compared to the known activity of Ahr in promoting IL-17
expression by Th17 cells in vitro, the role of Ahr in regulating
Th17 cells in vivo is still elusive. It has been reported that Ahr is
important for Th17 responses in the CNS during experimental
autoimmune encephalitis (Quintana et al., 2008; Veldhoen
et al., 2008). Surprisingly, we observed substantial upregulation
of gut Th17 cell responses in Ahr/mice under the steady state,
especially in the small intestine, thereby indicating an organ-
specific role of Ahr in regulating Th17 cell differentiation. Our
data further revealed an upregulation of SFB in Ahr-deficient
mice, consistent with a role for SFB in the induction of intestinal
Th17 cell responses (Gaboriau-Routhiau et al., 2009; Ivanov
et al., 2009). Indeed, antibiotic treatment can decrease Th17
cells in Ahr-deficient mice, demonstrating that the increase of
Th17 cells in Ahr-deficient mice is dependent on gut flora.
It has been shown that SFB are transmittable among mice
after cohousing (Ivanov et al., 2009). However, Ahr-deficientImmunity 39, 386–399, August 22, 2013 ª2013 Elsevier Inc. 393
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Figure 6. Exacerbated CD45RBhi T-Cell-Induced Colitis in Rag1–/–Ahr–/– Mice
A total of 43 105 CD4+CD25CD45RBhi splenocytes were sorted by flow cytometry and transferred to Rag1/Ahr/ (n = 5) or Rag1/Ahr+/+ (n = 5) littermate
mice. Mice in (C)–(F) were sacrificed at the end of the experiment.
(A) Body weight was monitored at the indicated time points. Results are shown as mean percentage of body-weight change ± SEM.
(B) Linear regression analysis of the body-weight change. Data are representative of four independent experiments. Horizontal lines show the mean. Error bars
represent the SEM.
(C) Representative colon histology of mice with the indicated genotypes is shown (H&E staining with original 103 magnification).
(D) Colonic histology scores are shown. Horizontal lines show the mean. Error bars represent the SEM.
(E and F) A total of 43 105 CD4+CD25CD45RBhi splenocytes were sorted by flow cytometry and transferred to Rag1/Ahr/ mice. Mice were gavaged with
200 ml/day of broad-spectrum antibiotics (‘‘abx’’) (1 g/l ampicillin, 1 g/l neomycin, 1 g/l metronidazole, 0.5 g/l vancomycin, and 1 g/l gentamycin) or water.
Representative colon histology of mice with the indicated groups (H&E staining with original 103magnification) is shown in (E). Histology scores are shown in (F).
Horizontal lines show the mean, error bars represent the SEM, and data are representative of two independent experiments.
See also Figure S5.
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birth still had substantially higher amounts of SFB, suggesting
that a host immune mechanism that controls the aberrant
outgrowth of SFB might be impaired in the absence of Ahr.
Consistent with this notion, Ahr-deficient mice had reduced
amounts of IL-22, a crucial cytokine that controls both patho-
genic (e.g., C. rodentium) and commensal (e.g., SFB) bacteria394 Immunity 39, 386–399, August 22, 2013 ª2013 Elsevier Inc.presumably by stimulating antimicrobial peptide production by
intestinal epithelial cells (Sonnenberg et al., 2011; Upadhyay
et al., 2012; Zheng et al., 2008). Indeed, Ahr-deficient mice
have reduced antimicrobial RegIIIg expression in the intestinal
epithelial cells (Qiu et al., 2012). Of note, given the observation
that compared to cohoused wild-type littermate controls, Ahr-
deficient mice showed no overt changes of gut microbiome
AB
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Figure 7. Enhanced Proinflammatory Cytokine Production by T Cells without Innate Expression of Ahr
A total of 43 105 CD4+CD25CD45RBhi splenocytes were sorted by flow cytometry and transferred to Rag1/Ahr/ (n = 5) or Rag1/Ahr+/+ (n = 5) littermate
mice.
(A) Large-intestinal LPLs were isolated and stimulated with PMA and ionomycin for 4 hr. Expression of IL-17 and IFN-g gated on CD4+TCRb+ cells was analyzed
by flow cytometry.
(B) Percentages of the indicated cell populations gated on CD4+TCRb+ cells are shown. Horizontal lines show the mean. Error bars represent the SEM. Data are
representative of two independent experiments.
(C) Small-intestinal (SI) or large-intestinal (LI) LPLs were isolated and stimulated with PMA and ionomycin for 4 hr. Expression of GM-CSF gated on CD4+TCRb+
cells was analyzed by flow cytometry. ‘‘SSC’’ stands for side scatter.
(D) Percentages of GM-CSF gated onCD4+TCRb+ cells are shown. Horizontal lines show themean. Error bars represent the SEM. Data are representative of three
independent experiments.
Immunity
Inhibition of Intestinal Th17 Responses by ILCspattern or overall bacterial load in the gut (Qiu et al., 2012), we
favor a model involving an active role for IL-22 in antagonizing
the specific outgrowth of SFB in the gut.
It has been shown that SFB colonization leads to improved
protection against C. rodentium infection by induction of intesti-
nal Th17 cells (Ivanov et al., 2009). Surprisingly, although Ahr/
mice have elevated SFB and consequently enhanced Th17
cell responses under the steady state, they succumb to
C. rodentium at an early stage of infection, in agreement with
the lack of innate RORgt+ ILCs that function as the first line of
host defense against the bacteria.
Increasing evidence suggests that certain innocuous
commensal bacteria can be pathogenic, depending on the
host genotype (Ivanov and Honda, 2012). For example, Bacter-
oides thetaiotaomicron, a well-characterized innocuous symbi-
otic species, induces strong colitis in mice deficient in IL-10
and TGF-b signaling pathways (Bloom et al., 2011). As innoc-
uous commensal bacteria, SFB do not induce any overt gut
pathology in wild-type mice in the steady-state conditions.Furthermore, SFB monocolonized mice do not develop sponta-
neous colitis (Ivanov et al., 2009). Our data show that in Ahr-
deficicent mice, outgrowth of SFB is associated with enhanced
Th17 cell responses and gut inflammation, suggesting that indig-
enous SFB might nevertheless lead to intestinal autoimmunity
through induction of pathogenic Th17 cell responses when the
host immune system is compromised (e.g., impaired group 3
ILCs and/or their production of IL-22).
Recently, it has been reported that IBD patients have
decreased expression of Ahr (Monteleone et al., 2011), in line
with the gut inflammation observed in Ahr-deficient mice. Strik-
ingly, we observed the development of spontaneous colitis in
Rorcgfp/+Ahr/mice under the SPF condition in our animal facil-
ity even thoughAhr/mice did not develop overt signs of colitis.
Compared to Ahr/ mice, Rorcgfp/+Ahr/ mice had further
decreased IL-22 produced by group 3 ILCs, consistent with our
previous data indicating the synergistic activity between Ahr
andRORgt in the regulation of IL-22 expression. Haplodeficiency
of RORgt might further weaken the intestinal innate lymphoidImmunity 39, 386–399, August 22, 2013 ª2013 Elsevier Inc. 395
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Inhibition of Intestinal Th17 Responses by ILCssystem of Ahr-deficient mice, thus leading to spontaneous
colitis. It is of interest to further examine the potential pathogenic
role of altered activity and/or expression level of RORgt in IBD
patients, particularly those with decreased expression of Ahr.
Our study indicates that ILCs and their effector cytokine IL-22
suppress Th17 responses (i.e., IL-17 production by T cells) in the
gut. The antagonism of intestinal IL-22 and IL-17 responses is
seemingly counterintuitive because of the coexpression of IL-
22 and IL-17 by certain T cells in inflammation (e.g., colitis) or
during infection (e.g., C. rodentium infection). Of note, although
IL-17 expression by T cells in the gut can be readily detected,
IL-22 is produced substantially less by intestinal Th17 cells
than by RORgt+ ILCs under the steady state (Qiu et al., 2012;
Sawa et al., 2011; Sonnenberg et al., 2011). Furthermore, certain
ILCs (NCR+ ILC3s) and T cells (Th22 cells) only produce IL-22,
but not IL-17 (Basu et al., 2012; Sawa et al., 2010), suggesting
an intriguing mutually exclusive expression pattern of these
two cytokines in vivo in physiological conditions.
IL-22 is a dual-natured cytokine that exerts both protective
and inflammatory functions, most likely depending on the inflam-
matory context, for example, the duration and amount of IL-22
present, the overall cytokine microenvironment, and the tissues
and/or cell types involved (Zenewicz and Flavell, 2011). Under
the steady state, in addition to preventing pathogenic bacterial
infection (e.g., C. rodetnium), IL-22 secreted by group 3 ILCs
presumably at a physiological level is essential for controlling
outgrowth of certain commensal bacterial (e.g., SFB), thereby
suppressing overt proinflammatory T cell responses to maintain
gut immune homeostasis. However, during intestinal autoimmu-
nity, when adaptive immune responses are overwhelming, large
amounts of IL-22 secreted by T cells could be pathogenic by
stimulating the proliferation of colon epithelial cells and causing
mucosal hyperplasia (Kamanaka et al., 2011). Exuberant IL-22
together with other proinflammatory cytokines (e.g., IFN-g and
IL-17) might create a cytokinemilieu that promotes tissue inflam-
mation. Consistent with this notion, IL-22 secreted by RORgt+
ILCs or Th17 cells has recently been reported to play differential
roles in a graft-versus-host-disease model (Hanash et al., 2012).
Future studies are needed for examining the functional differ-
ence between IL-22 produced by T cells or ILCs in the intestinal
immune responses.
The cross-regulation between innate and adaptive immune
systems is important for the immune balance in the gut. In this
study, we uncovered a role for the Ahr-IL-22 axis in group 3
ILCs in suppressing inflammatory Th17 cell responses to main-
tain gut homeostasis. Perturbation of ILC development and/or
function (e.g., production of IL-22)might not only impair intestinal
immunity against pathogen infection but also induce autoimmu-
nity in the gut by disturbing commensal flora. The relationship
between ILCs and T helper cells that share a number of common
features (e.g., transcription factor requirement, cytokine profile,
and anatomic location) in different disease settings warrants
further investigation.EXPERIMENTAL PROCEDURES
Mice
All mice used in this study were maintained in SPF facilities at Northwestern
University. The mice were littermate controlled and were 6–10 weeks old un-396 Immunity 39, 386–399, August 22, 2013 ª2013 Elsevier Inc.less otherwise indicated in the text. C57BL/6 Thy1.1 mice was purchased
from Jackson Laboratory (Bar Harbor, ME) and used upon arrival. Rag1/
mice were originally purchased from Jackson Laboratory but were maintained
at Northwestern University animal facility to acquire SFB. C57BL/6 mice were
purchased from Taconic Farms. Ahr–/– (Fernandez-Salguero et al., 1995) and
Rorcgfp/gfp (Eberl et al., 2004) mice were generated previously. All studies
with mice were approved by the Animal Care and Use Committee of North-
western University.
Antibiotic Treatment
Mice were supplied with autoclaved water supplemented with or without anti-
biotics (1 g/l ampicillin, 1 g/l gentamicin, 1 g/l metronidazole, 1 g/l neomycin,
and 0.5 g/l vancomycin) for 10 days or were treated by gavage as indicated
in the text.
IL-22 Antibody and IL-22-Ig Treatment
IL-22-Ig and the monoclonal antibody against murine IL-22 were kindly
provided by W. Ouyang (Genetech). Wild-type mice were intraperitoneally in-
jected with 90 mg anti-mIL-22 every 4 days. Ahr/mice were intraperitoneally
injected with 25 mg IL-22-Ig once.
T-Cell-Transfer Colitis
Splenocytes were collected from 6- to 8-week-old wild-type mice or Thy1.1+
C57BL/6 mice. CD4+CD25CD45RBhi cells were sorted by flow cytometry,
and 4 3 105 cells were injected into Rag1/ or Rag1/Ahr/ mice. The
mice were weighed at various time points for the monitoring of colitis
development.
Thy1 Depletion in Rag-Deficient Mice
Rag1/ mice were injected with 250 mg anti-Thy1.2 (30H12) purchased from
BioXCell without T cell transfer or on the same day of adoptive T cell transfer
and every 3 days afterward.
Histological Analysis
Tissues from middle colon were dissected and fixed with 10% formalin.
Tissues were then embedded in paraffin, sectioned at 4 mm, and stained
with hematoxylin and eosin. Sections were then blindly analyzed by a trained
gastrointestinal pathologist. Histology scores were given with a standard
described previously (Pavlick et al., 2006). The seven parameters used include
(1) lamina propria inflammation (0–3), (2) goblet cell loss (0–2), (3) abnormal
crypts (0–3), (4) crypt abscesses (0–1), (5) mucosal erosion or ulceration
(0–1), (6) submucosal spread to transmural inflammation (0–4), and (7) neutro-
phil counts (0–4). The severity of inflammation in sections of the colon was
based on the sum of the scores in each parameter (maximum score = 18).
Isolation of Intestinal LPLs
The isolation of intestinal lamina proprial cells was done as previously
described (Qiu et al., 2012). In brief, the large and small intestines were
dissected. Fat tissues and Peyer’s patches were removed. Intestines were
cut open longitudinally and washed in PBS. Intestines were then cut into
5 cm pieces, washed, and shaken in PBS containing 1 mM DTT for 10 min
at room temperature. Intestines were incubated with shaking in PBS contain-
ing 30mMEDTA and 10mMHEPES at 37C for 10min for two cycles. For fetal
and 1-week-old mice, intestines were cut into 1 mm pieces. The tissues were
then digested in RPMI1640 medium (Invitrogen) containing DNase I (Sigma)
(150 mg/ml) and collagenase VIII (Sigma) (100 U/ml for the small intestine
and 200 U/ml for the large intestine) at 37C in 5% CO2 incubator for 1.5 hr.
The digested tissues were homogenized by vigorous shaking and passed
through a 100 mm cell strainer. Mononuclear cells were then harvested from
the interphase of an 80% and 40% Percoll gradient after a spin at 2,500 rpm
for 20 min at room temperature.
Flow Cytometry
CD16/32 antibody was used to block the nonspecific binding to Fc receptors
before all surface stainings. Antibodies were purchased from eBioscience or
BD PharMingen. For nuclear staining, cells were fixed and permeabilized
with a Mouse Regulatory T Cell Staining Kit (eBioscience). For cytokine pro-
duction, cells were stimulated ex vivo by 50 ng/ml PMA and 500 ng/ml
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Inhibition of Intestinal Th17 Responses by ILCsionomycin for 4 hr. Brefeldin A (2 mg/ml) was added 2 hr before cells were har-
vested for analysis. Dead cells were excluded from the analysis with the Live
and Dead Violet Viability Kit (Invitrogen).
Bacterial DNA Extraction and Real-Time PCR
Fecal pellets or ileum contents were collected from mice, and bacterial DNA
was extracted with the QIAamp DNA Stool Kit (QIAGEN). Quantitative PCR
for the 16S rRNA genewas performedwith SYBRGreen (Bio-Rad) and normal-
ized to total bacterial DNA. Reactions were run with the MyiQ2 Two-Color
Real-Time PCR Detection System (Bio-Rad). Primers used in this study have
been described previously (Atarashi et al., 2011; Barman et al., 2008). Specific
primers for Eubacteria (all bacteria) were UniF340 50-ACTCCTACGGGAGG
CAGCAGT-30 and UniR514 50-ATTACCGCGGCTGCTGGC-30. Specific
primers for SFB were SFB736F 50-GACGCTGAGGCATGAGAGCAT-30 and
SFB844R 50-GACGGCACGGATTGTTATTCA-30. Specific primers for Clostri-
diales were LabF362 50-AGCAGTAGGGAATCTTCCA-30 and LabR677 50-
CACCGCTACACATGGAG-30. Specific primers for Bacteroides were
BactF285 50-GGTTCTGAGAGGAGGTCCC-30 and UniR338 50-GCTGCCTC
CCGTAGGAGT-30. Specific primers for Lactobacillaceae were LabF362 50-
AGCAGTAGGGAATCTTCCA-30 and LabR677 50-CACCGCTACACATG
GAG-30. Specific primers for Clostridium Leptum were 50-CCTTCCGTG
CCGSAGTTA-30 and 50-GAATTAAACCACATACTCCACTGCTT-30. Specific
primers for Clostridium coccoides were 50-AAATGACGGTACCTGACTAA-30
and 50-CTTTGAGTTTCATTCTTGCGAA-30. Specific primers for Enterobacter-
iaceae were Uni515F 50-GTGCCAGCAGCCGCGGTAA-30 and Ent826R 50-
GCCTCAAGGGCACAACCTCCAAG-30.
Statistical Methods
Unless otherwise noted, statistical analysis was performed with the unpaired
Student’s t test on individual biological samples. Linear regression analysis
was performed with GraphPad Prism. *p < 0.05; **p < 0.01; ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
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